Publicaciones en las que colabora con Pedro Sánchez Rovira (14)

2020

  1. Drug repurposing for triple-negative breast cancer

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-34

2019

  1. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways

    European Journal of Nutrition, Vol. 58, Núm. 8, pp. 3207-3219

  2. Modulation by hydroxytyrosol of oxidative stress and antitumor activities of paclitaxel in breast cancer

    European Journal of Nutrition, Vol. 58, Núm. 3, pp. 1203-1211

2018

  1. Activating transcription factor 4 modulates TGFb-induced aggressiveness in triple-negative breast cancer via SMad2/3/4 and mTORC2 signaling

    Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5697-5709

2017

  1. A plasma metabolomic signature discloses human breast cancer

    Oncotarget, Vol. 8, Núm. 12, pp. 19522-19533

2014

  1. Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer

    Biochemical Pharmacology, Vol. 90, Núm. 1, pp. 25-33

2013

  1. Impact of Diet on Breast Cancer Risk: A Review of Experimental and Observational Studies

    Critical Reviews in Food Science and Nutrition, Vol. 53, Núm. 1, pp. 49-75

2012

  1. Oxidative stress status in metastatic breast cancer patients receiving palliative chemotherapy and its impact on survival rates

    Free Radical Research, Vol. 46, Núm. 1, pp. 2-10

2011

  1. Does chemotherapy-induced oxidative stress improve the survival rates of breast cancer patients?

    Antioxidants and Redox Signaling, Vol. 15, Núm. 4, pp. 903-909

  2. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies

    Critical Reviews in Oncology/Hematology, Vol. 80, Núm. 3, pp. 347-368

  3. Hydroxytyrosol inhibits growth and cell proliferation and promotes high expression of sfrp4 in rat mammary tumours

    Molecular Nutrition and Food Research, Vol. 55, Núm. SUPPL. 1

2010

  1. Hydroxytyrosol: From laboratory investigations to future clinical trials

    Nutrition Reviews, Vol. 68, Núm. 4, pp. 191-206

  2. New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients

    Food and Chemical Toxicology, Vol. 48, Núm. 6, pp. 1425-1438

  3. Virgin olive oil minor components as natural drugs for the treatment of breast cancer: Preliminary experiments on squalene

    Mediterranean Journal of Nutrition and Metabolism, Vol. 3, Núm. 3, pp. 221-225